Shattuck Labs, Inc. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
Shattuck Labs, Inc. (STTK) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $190.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2021-11-09
- 2021-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $190.00K.
- 2021-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $327.00K.
- 2021-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $702.00K.
- 2020-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $73.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2021-09-30 | $190.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $327.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $702.00K 10-Q · filed 2021-05-10 |
| 2020-09-30 | $73.00K 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |